ISF Limited Q2 FY27: PBT ₹0.08 cr as revenue slips
Ask Iris
Key takeaway from the September quarter
ISF Limited reported weaker profitability for the quarter ended September 30, 2026, with profit before tax (PBT) falling year-on-year. The company’s revenue from operations also declined compared with the same quarter last year, indicating pressure on the top line. The unaudited standalone financial results were approved by the Board of Directors at a meeting held on October 23, 2026. The statutory auditors, VSSA & Associates, issued a limited review report with an unmodified opinion on the statements prepared under Ind AS 34. Alongside results, the Board also considered a proposal related to inter-corporate deposits and loans.
What the company reported for Q2 FY27
For the quarter ended September 30, 2026, ISF Limited reported PBT of ₹0.0835 crore. This was lower than ₹0.1568 crore reported in the corresponding period last year. Revenue from operations came in at ₹0.3107 crore, down from ₹0.4477 crore in Q2 FY26. The company’s update also noted that the top line contracted significantly on a year-on-year basis. While operating expenses decreased, the decline was not sufficient to offset the drop in revenue, leading to lower profitability. Other income contributed marginally to total income, rising to ₹0.0024 crore from nil in the previous year.
Board approval and audit review details
The Board of Directors approved the unaudited financial results at its meeting on October 23, 2026. The statutory auditors, VSSA & Associates, issued a limited review report with an unmodified opinion. The results were prepared under Ind AS 34, which is the accounting standard used for interim financial reporting. An unmodified opinion, as stated in the update, indicates the auditors did not report any modifications to their conclusion in the limited review. The disclosures in the provided text focus on the standalone financial statements.
Expenses fell, but not enough to protect margins
The company indicated that operating expenses decreased during the quarter. However, the drop in expenses did not compensate for the sharper fall in revenue from operations. In practical terms, this means the cost base came down but the business generated less operating revenue, compressing profitability at the pre-tax level. The update does not provide line-item expense numbers, but it clearly attributes lower profitability to the revenue decline outweighing cost reductions. Other income increased to ₹0.0024 crore from nil, but the contribution was described as marginal.
Inter-corporate deposits and loans: what the Board approved
In addition to approving the quarterly results, the Board considered and approved a proposal to avail Inter-Corporate Deposits (ICDs) or inter-corporate loans up to an aggregate amount of ₹11 crore. The approval is stated to be subject to applicable provisions of the Companies Act, 2013, SEBI Listing Regulations, and RBI directions. The text does not specify timing, counterparties, pricing, or end-use for the proposed ICDs or loans. It also does not indicate whether the facility is immediately drawn or only approved as an enabling resolution. Still, the approval provides the company flexibility to raise funds within the stated limit under the applicable regulatory framework.
Snapshot of reported numbers (normalized to ₹ crore)
Corporate actions and disclosure trail on results
The provided information also lists corporate action dates around quarterly results disclosures for ISF Limited. These entries are presented as “Stock Result” events with ex-dates mentioned in the source. The sequence helps place the Q2 result in context with recent quarterly reporting.
Separate regulatory headline mentioned in the feed
The supplied text also includes a separate headline: “Sebi orders attachment of bank, demat a/c of ISF Securities.” No additional details of the order, scope, dates, or entities covered are included in the excerpt beyond the headline. As a result, the specific reasons, proceedings, and implications cannot be described from the provided content alone. Readers should refer to the full regulator order or the complete news report for verified details.
Business context mentioned: NBFC registration
The text describes ISFL as a Non-Systematically Important Non-Deposit Taking Non-Banking Financial Company (NBFC) active in India’s retail finance sector. For such entities, quarterly reporting and regulatory disclosures are typically watched for signals on growth, funding access, and earnings stability. In this quarter, the headline story is the year-on-year contraction in revenue from operations and the accompanying decline in pre-tax profitability. The additional Board approval for ICDs or inter-corporate loans indicates the company is also keeping funding options available within a stated aggregate limit.
Why this quarter matters for investors tracking ISF Limited
The Q2 FY27 numbers show that ISF Limited’s operating revenue fell year-on-year, and cost reductions were not enough to maintain the prior-year level of profitability. The rise in other income was small in absolute terms, so operating performance remained the key driver of the change. The Board-approved plan to avail up to ₹11 crore through ICDs or inter-corporate loans is a material governance update because it sets an upper limit for potential borrowing under the relevant legal and regulatory provisions. The auditors’ unmodified conclusion on the limited review and the reference to Ind AS 34 provide comfort on the form of interim reporting, though the review is not the same as a full audit.
Conclusion
ISF Limited’s Q2 FY27 standalone results, approved on October 23, 2026, reflected a year-on-year decline in both revenue from operations and profit before tax, with other income making only a marginal difference. The same Board meeting also approved a proposal to avail ICDs or inter-corporate loans up to ₹11 crore, subject to applicable regulations. The next set of updates investors typically track will be subsequent exchange filings and future quarterly results disclosures as per the company’s reporting cycle.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker